INOFEA is a Manufacturer/Innovator, Contract Service, CMO/CDMO, Biopharmaceutical company, Contract Research Organisation (CRO) company operating in the pharmaceutical industry.
INOFEA, a Swiss biotech company founded in 2014, develops enzyme-based solutions for optimizing the synthesis of Biologics like mRNA vaccines, therapeutics, and ADCs. Our patented technology enhances enzyme stability and activity without loss during the process, resulting in purer products, cost-saving potential, and faster market entry. The technology can be applied in biocatalytic process steps for small molecule APIs where soluble enzymes are insufficiently stable, preserving activity under challenging conditions.
Company type
Manufacturer/Innovator, Contract Service, CMO/CDMO, Biopharmaceutical company, Contract Research Organisation (CRO)
Products and services
Biopharmaceuticals, Intermediates, Fine and Specialty Chemicals
Markets
North America (USA, Canada), Europe – EU countries
Address
INOFEA, Hofackerstrasse 40b, Muttenz, Switzerland, 4132
